We have uncovered novel mechanisms of serotonergic signaling that may underlie brain and gut differences in autism spectrum disorders (ASD). We have developed a novel screen for assessing GI disorders in children with ASD. Our preclinical studies are focused on We examining the underlying mechanisms associated with GI dysfunction in individuals with Angelman Syndrome. Our clinical studies are investigating the effects of diet of behavioral and GI outcomes in children with ASD.